BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 3175816)

  • 1. [Advanced abdominal non-Hodgkin's lymphoma in the child. Features and response to treatment].
    Lobo-Sanahuja F; García I; Vargas G; Barrantes J; Jiménez E; Jiménez R
    Sangre (Barc); 1988 Jun; 33(3):196-201. PubMed ID: 3175816
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-Hodgkin's lymphoma in children. Results of therapy.
    Cáp J; Misíková Z; Foltinová A
    Neoplasma; 1987; 34(6):735-44. PubMed ID: 2448663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Results of modified LSA2-L2 protocol with moderate-dose MTX therapy in children with untreated non-Hodgkin's lymphoma].
    Shimamoto Y; Imai S; Endo N
    Gan To Kagaku Ryoho; 1992 Mar; 19(3):395-8. PubMed ID: 1543367
    [No Abstract]   [Full Text] [Related]  

  • 4. [Termination of the treatment of children with non-Hodgkin's lymphoma after its recurrence].
    Dłuzniewska A; Balwierz W; Kwinta J
    Pol Tyg Lek; 1989 Oct 2-16; 44(40-42):882-4. PubMed ID: 2487943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies of childhood non-Hodgkin's lymphoma--treatment results with the CCLSG NHL 960 protocol. Children's Cancer and Leukemia Study Group (CCLSG)].
    Tsurusawa M; Katano N; Hirota T; Ito M; Yanase T; Asami K; Koizumi S; Nakayama M; Miyawaki T; Suzumiya J; Nishikawa K; Mugisima H; Horikoshi Y; Hatae Y; Iwai A; Anami K; Kikuchi M; Osima K; Kaneko Y; Kataoka S; Tanaka A; Chin M; Taga T; Watanabe A; Fujimoto T
    Rinsho Ketsueki; 1998 Nov; 39(11):1092-8. PubMed ID: 9866420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors.
    Bessell EM; Graus F; Lopez-Guillermo A; Lewis SA; Villa S; Verger E; Petit J
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):501-8. PubMed ID: 15145169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Plasmacytoid dendritic cell tumor].
    Pérez-Crespo M; Moragón M; Onrubia J; Sevila A; Alfonso R; Miralles J; Requena L
    Actas Dermosifiliogr; 2011 Apr; 102(3):229-31. PubMed ID: 21232729
    [No Abstract]   [Full Text] [Related]  

  • 8. [THP-COP, BHAC-VMP alternating chemotherapy in patients with non-Hodgkin's lymphoma].
    Imura H; Ito N; Shirakawa S; Sobue R; Maruyama F; Kojima H; Shinkai K; Matsui T; Ino T; Shimizu K
    Rinsho Ketsueki; 1988 May; 29(5):688-93. PubMed ID: 3216495
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment results and prognostic significance of selected clinical and laboratory features in children diagnosed with malignant lymphoma].
    Kamieńska E
    Ann Acad Med Stetin; 1996; 42():105-22. PubMed ID: 9199116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-hodgkins lymphoma.
    Mead G; Woodcock J; Young C
    Clin Evid; 2003 Jun; (9):1-21. PubMed ID: 12967352
    [No Abstract]   [Full Text] [Related]  

  • 11. [Non-Hodgkin's lymphoma among the cases of the Institute of Pediatrics, Polish Academy of Medicine].
    Nowakowska J; Chełkowska H; Chlebcewicz-Szuba W; Urasiński T; Skwira J; Podraza W
    Pol Tyg Lek; 1988 Jul; 43(28):913-6. PubMed ID: 3247262
    [No Abstract]   [Full Text] [Related]  

  • 12. [The chemoradiation treatment of patients with aggressive non-Hodgkin's lymphomas in the III-IV stages of the disease].
    Sotnikov VM; Pan'shin GA; Pivnik AV; Grigor'eva MA
    Ter Arkh; 1992; 64(7):54-6. PubMed ID: 1440370
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemoradiotherapy for localized non-Hodgkin's lymphoma: lessons from old studies.
    Basaran G; Basaran M; Onat H
    J Clin Oncol; 2005 May; 23(13):3161-2; author reply 3162-3. PubMed ID: 15860887
    [No Abstract]   [Full Text] [Related]  

  • 14. CHOP versus intensive regimens in non-Hodgkin's lymphoma.
    Longo DL; DeVita VT; Young RC
    N Engl J Med; 1993 Aug; 329(8):580-1; author reply 581-2. PubMed ID: 7687747
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chemotherapy for advanced diffuse non-Hodgkin's lymphoma with non-cross-resistant alternating AVCP/EMLP regimens].
    Yamazaki H; Ogawa M; Horikoshi N; Inagaki J; Inoue K; Nakamura T; Ueno K; Ito Y; Imajo K; Mukaiyama T
    Nihon Ketsueki Gakkai Zasshi; 1986 Nov; 49(7):1404-11. PubMed ID: 3825458
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of two different ProMACE-CytaBOM derived regimens in advanced aggressive non-Hodgkin's lymphoma. Final report of a multicenter trial conducted by GISL.
    Federico M; Clò V; Brugiatelli M; Carotenuto M; Gobbi PG; Vallisa D; Lombardo M; Avanzini P; Di Renzo N; Dini D; Baldini L; Silingardi V
    Haematologica; 1998 Sep; 83(9):800-11. PubMed ID: 9825577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Childhood CD4+/CD56+ hematodermic neoplasm: case report and review of the literature.
    Ruggiero A; Maurizi P; Larocca LM; Arlotta A; Riccardi R
    Haematologica; 2006 Dec; 91(12 Suppl):ECR48. PubMed ID: 17194654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of intermediate-grade and high-grade non-Hodgkin's lymphoma.
    Kosmas C; Malamos NA; Antonopoulos MJ
    N Engl J Med; 1998 Nov; 339(20):1476; author reply 1477. PubMed ID: 9841319
    [No Abstract]   [Full Text] [Related]  

  • 19. [Non-Hodgkin's lymphomas: recent achievements and therapeutic perspectives].
    Bron D; Vandenheule B; Stryckmans P
    Rev Med Brux; 1985 Sep; 6(7):491-5. PubMed ID: 2417298
    [No Abstract]   [Full Text] [Related]  

  • 20. [A case of lymphoma of a higher stage of malignancy treated with cytostatics and interferon].
    Cieślińska A
    Pol Tyg Lek; 1988 Jul; 43(28):917-8. PubMed ID: 3247263
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.